Lim Bryant David has filed 5 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 275000 shares of Prelude Therapeutics Inc ($PRLD) on February 04, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 4, 2026 | Prelude Therapeutics Inc | $PRLD | Lim Bryant David | CLO, CFO, Corp Sec. | A | Employee Stock Option (right to buy) | 275000 | $0.00 | 275,000.0000 | 76,132,337 | 9999.99% | 0.36% |
| Feb. 4, 2025 | Prelude Therapeutics Inc | $PRLD | Lim Bryant David | CLO, CFO, Corp Sec. | A | Employee Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 75,805,840 | 9999.99% | 0.26% |
| Dec. 19, 2024 | Prelude Therapeutics Inc | $PRLD | Lim Bryant David | CLO, Interim CFO, Corp Sec. | P | Common Stock | 25000 | $0.91 | 27,400.0000 | 75,855,949 | 1041.67% | 0.03% |
| May 14, 2024 | Prelude Therapeutics Inc | $PRLD | Lim Bryant David | CLO, Interim CFO, Corp Sec. | A | Employee Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 60,357,052 | 9999.99% | 0.04% |
| March 1, 2024 | Prelude Therapeutics Inc | $PRLD | Lim Bryant David | Chief Legal Officer, Corp Sec. | A | Employee Stock Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 60,357,052 | 9999.99% | 0.25% |